{"id":4901,"date":"2021-08-28T12:35:10","date_gmt":"2021-08-28T09:35:10","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=4901"},"modified":"2021-08-30T14:30:16","modified_gmt":"2021-08-30T11:30:16","slug":"covid-19a-yakalanmak-asidan-daha-fazla-bagisiklik-kazandiriyor-ancak-covid-19un-riskleri-dikkate-alindiginda-asi-cok-daha-guvenli","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/covid-19a-yakalanmak-asidan-daha-fazla-bagisiklik-kazandiriyor-ancak-covid-19un-riskleri-dikkate-alindiginda-asi-cok-daha-guvenli\/","title":{"rendered":"COVID-19&#8217;a Yakalanmak A\u015f\u0131dan Daha Fazla Ba\u011f\u0131\u015f\u0131kl\u0131k Kazand\u0131r\u0131yor, Ancak COVID-19&#8217;un Riskleri Dikkate Al\u0131nd\u0131\u011f\u0131nda A\u015f\u0131 \u00c7ok Daha G\u00fcvenli"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\" wp-image-57654 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2016\/12\/Euronews._2016_alternative_logo.png\" alt=\"\" width=\"54\" height=\"54\" \/><strong>COVID-19&#8217;a kar\u015f\u0131 \u00fclke n\u00fcfusunun y\u00fczde 72&#8217;sini Pfizer-BioNTech ile a\u015f\u0131layan \u0130srail&#8217;de a\u015f\u0131n\u0131n g\u00fcvenli\u011fi ve etkinli\u011fine dair ara\u015ft\u0131rmalar arka arkaya geliyor. Son olarak a\u015f\u0131n\u0131n etkinli\u011fine dair y\u00fcr\u00fct\u00fclen kapsaml\u0131 bir ara\u015ft\u0131rma bir kez COVID-19&#8217;a yakalanman\u0131n Pfizer-BioNTech a\u015f\u0131s\u0131n\u0131n delta varyant\u0131na kar\u015f\u0131 sa\u011flad\u0131\u011f\u0131 ba\u011f\u0131\u015f\u0131kl\u0131ktan \u00e7ok daha koruyucu oldu\u011funu ortaya koydu. Ancak uzmanlar, a\u015f\u0131lanmam\u0131\u015f ki\u015filerin bilerek hastal\u0131\u011fa yakalanmaya \u00e7al\u0131\u015fmas\u0131n\u0131n \u00e7ok riskli oldu\u011funa dikkat \u00e7ekerek b\u00f6yle bir giri\u015fimin \u00f6l\u00fcmle bile sonu\u00e7lanabilece\u011fini dile getiriyor. \u00c7al\u0131\u015fman\u0131n do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n faydalar\u0131na dikkat \u00e7ekti\u011fi, ancak virusun v\u00fccuda girdikten sonra yapt\u0131\u011f\u0131 tahribat\u0131 dikkate almad\u0131\u011f\u0131 vurgulan\u0131yor.<\/strong><\/p>\n<p>Ara\u015ft\u0131rmaya g\u00f6re ayr\u0131ca, COVID-19 hastal\u0131\u011f\u0131 ge\u00e7irdikten sonra bir doz Pfizer-BioNTech a\u015f\u0131s\u0131 olanlar\u0131n hi\u00e7 a\u015f\u0131 olmayanlara k\u0131yasla yeniden hastalanmaya kar\u015f\u0131 \u00e7ok daha y\u00fcksek koruma sa\u011fl\u0131yor.<\/p>\n<p>medRxiv&#8217;te yay\u0131nlanan ancak hen\u00fcz ba\u011f\u0131ms\u0131z uzman de\u011ferlendirmesi yap\u0131lmayan ara\u015ft\u0131rmada 2 bu\u00e7uk milyon \u0130srailli&#8217;nin COVID-19&#8217;la ba\u011flant\u0131l\u0131 belirti, hastal\u0131k ve hastaneye yat\u0131\u015f bilgilerinin topland\u0131\u011f\u0131 Maccabi Sa\u011fl\u0131k Hizmetleri&#8217;nce 1 Temmuz-14 A\u011fustos tarihleri aras\u0131nda toplanan veriler analiz edildi.<\/p>\n<p><strong>&#8220;Aradaki Fark \u00c7ok B\u00fcy\u00fck&#8221;<\/strong><\/p>\n<p>Bu verilerle yap\u0131lan iki analizde Ocak ve \u015eubat aylar\u0131nda a\u015f\u0131 olanlar\u0131n Haziran, Temmuz ve A\u011fustosun ilk yar\u0131s\u0131nda hastal\u0131\u011fa yakalanma oran\u0131n\u0131n daha \u00f6nce COVID-19 ge\u00e7irmi\u015f olanlara k\u0131yasla 6 ila 13 kez fazla oldu\u011funu ortaya koydu.<\/p>\n<p>Sa\u011fl\u0131k sistemine kay\u0131tl\u0131 32 bin ki\u015finin verilerinin k\u0131yasland\u0131\u011f\u0131 ilk analizde a\u015f\u0131lanm\u0131\u015f ki\u015filerin COVID-19 ge\u00e7irenlere g\u00f6re semptomatik COVID-19&#8217;a yakalanma ihtimalinin 27 kat, hastaneye yatma riskinin ise 8 kat fazla oldu\u011funu g\u00f6sterdi.<\/p>\n<p>14 bin ki\u015finin verilerinin de\u011ferlendirildi\u011fi di\u011fer bir analizde ise COVID-19 hastal\u0131\u011f\u0131 te\u015fhisi konmu\u015f ancak hi\u00e7 a\u015f\u0131 olmam\u0131\u015f ki\u015filer ile hastaland\u0131ktan sonra \u0130srail&#8217;deki uygulama do\u011frultusunda yaln\u0131zca bir doz Pfizer-BioNTech a\u015f\u0131s\u0131 olmu\u015f ki\u015filerin verileri k\u0131yasland\u0131. Bu analizin sonucunda a\u015f\u0131lanmam\u0131\u015f grubun tek doz a\u015f\u0131lanm\u0131\u015f gruba k\u0131yasla iki kat daha fazla yeniden hastalanma ihtimali bulundu\u011fu anla\u015f\u0131ld\u0131.<\/p>\n<p><strong>&#8220;Bu COVID-19 Partisine Davetiye De\u011fil&#8221;<\/strong><\/p>\n<p>\u00c7al\u0131\u015fman\u0131n \u00f6n raporunu de\u011ferlendiren \u0130sve\u00e7&#8217;teki Danderyd Hastanesi ve Karolinska Enstit\u00fcs\u00fc hekimlerinden imm\u00fcnoloji uzman\u0131 Charlotte Thalin &#8220;aradaki fark\u0131n \u00e7ok b\u00fcy\u00fck&#8221; oldu\u011funa dikkat \u00e7ekerek bu \u00e7al\u0131\u015fman\u0131n do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n a\u015f\u0131lamaya g\u00f6re ne kadar etkin oldu\u011funun tipik bir \u00f6rne\u011fi oldu\u011funu belirtiyor.<\/p>\n<p>Ancak bilerek COVID-19&#8217;a yakalanman\u0131n a\u011f\u0131r hastal\u0131k ve \u00f6l\u00fcm riskinin yan\u0131 s\u0131ra uzun soluklu ve g\u00fcndelik hayat\u0131 olumsuz etkileyen belirti ve hastal\u0131k riskini de beraberinde getirebilece\u011fi uyar\u0131s\u0131n\u0131 yapan Thalin ve di\u011fer uzmanlar bu ara\u015ft\u0131rman\u0131n bir COVID-19 partisine davetiye olmad\u0131\u011f\u0131n\u0131n alt\u0131n\u0131 \u00e7iziyor.<\/p>\n<p>\u0130srail&#8217;de yap\u0131lan bir ba\u015fka yeni ara\u015ft\u0131rma Pfizer-BioNTech a\u015f\u0131s\u0131n\u0131n yan etkilerine ra\u011fmen COVID-19 hastal\u0131\u011f\u0131n\u0131 yol a\u00e7abilece\u011fi sa\u011fl\u0131k sorunlar\u0131 dikkate al\u0131nd\u0131\u011f\u0131nda \u00e7ok daha g\u00fcvenli oldu\u011funu ortaya koymu\u015ftu. (<a href=\"https:\/\/www.klimik.org.tr\/koronavirus\/biontech-asisinin-yan-etkilerine-dair-en-kapsamli-calisma-yayimlandi-asi-akut-myokard-infarktusu-ve-tromboz-riskini-artirmazken-covid-19-artiriyor\/\">\u0130lgili Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z.<\/a>)<\/p>\n<p><a href=\"https:\/\/tr.euronews.com\/2021\/08\/27\/arast-rma-covid-19-a-yakalanmak-as-dan-daha-fazla-bag-s-kl-k-kazand-r-yor\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COVID-19&#8217;a kar\u015f\u0131 \u00fclke n\u00fcfusunun y\u00fczde 72&#8217;sini Pfizer-BioNTech ile a\u015f\u0131layan \u0130srail&#8217;de a\u015f\u0131n\u0131n g\u00fcvenli\u011fi ve etkinli\u011fine dair ara\u015ft\u0131rmalar arka arkaya geliyor. Son olarak a\u015f\u0131n\u0131n etkinli\u011fine dair y\u00fcr\u00fct\u00fclen kapsaml\u0131 bir ara\u015ft\u0131rma bir kez COVID-19&#8217;a yakalanman\u0131n Pfizer-BioNTech a\u015f\u0131s\u0131n\u0131n delta varyant\u0131na kar\u015f\u0131 sa\u011flad\u0131\u011f\u0131 ba\u011f\u0131\u015f\u0131kl\u0131ktan \u00e7ok daha koruyucu oldu\u011funu ortaya koydu. Ancak uzmanlar, a\u015f\u0131lanmam\u0131\u015f ki\u015filerin bilerek hastal\u0131\u011fa yakalanmaya \u00e7al\u0131\u015fmas\u0131n\u0131n \u00e7ok riskli oldu\u011funa dikkat \u00e7ekerek b\u00f6yle bir giri\u015fimin \u00f6l\u00fcmle bile sonu\u00e7lanabilece\u011fini dile getiriyor. \u00c7al\u0131\u015fman\u0131n do\u011fal ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n faydalar\u0131na dikkat \u00e7ekti\u011fi, ancak virusun v\u00fccuda girdikten sonra yapt\u0131\u011f\u0131 tahribat\u0131 dikkate almad\u0131\u011f\u0131 vurgulan\u0131yor. Ara\u015ft\u0131rmaya g\u00f6re ayr\u0131ca, COVID-19 hastal\u0131\u011f\u0131 ge\u00e7irdikten sonra bir doz Pfizer-BioNTech a\u015f\u0131s\u0131 olanlar\u0131n hi\u00e7 a\u015f\u0131 olmayanlara k\u0131yasla yeniden hastalanmaya [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":4902,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4901"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=4901"}],"version-history":[{"count":2,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4901\/revisions"}],"predecessor-version":[{"id":4905,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/4901\/revisions\/4905"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/4902"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=4901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=4901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=4901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}